Figure 3. Time to Complete Remission by Age.
Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE) included 166 participants, with 64 events; focal segmental glomerulosclerosis clinical trial (FSGS-CT) included 132 participants, with 50 events. The pooled analysis included 298 participants with 114 events.